10.07.2015 Views

BNF for Children 2011-2012

BNF for Children 2011-2012

BNF for Children 2011-2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>BNF</strong>C <strong>2011</strong>–<strong>2012</strong> 5.1.1 Penicillins 261of Staph. aureus, E. coli, and H. influenzae, as well asmany Bacteroides and Klebsiella spp. Co-amoxiclavshould be reserved <strong>for</strong> infections likely, or known, tobe caused by amoxicillin-resistant beta-lactamase-producingstrains.A combination of ampicillin with flucloxacillin (as cofluampicil)is available to treat infections involvingeither streptococci or staphylococci (e.g. cellulitis).Lyme disease Lyme disease should generally betreated by those experienced in its management. Amoxicillin[unlicensed indication], cefuroxime axetil ordoxycycline are the antibacterials of choice <strong>for</strong> earlyLyme disease or Lyme arthritis but doxycycline shouldonly be used in children over 12 years of age. If theseantibacterials are contra-indicated, a macrolide (e.g.clarithromycin) can be used <strong>for</strong> early Lyme disease.Intravenous administration of ceftriaxone, cefotaxime(section 5.1.2.1), or benzylpenicillin (p. 258) is recommended<strong>for</strong> Lyme disease associated with cardiac orneurological complications. The duration of treatment isusually 2–4 weeks; Lyme arthritis may require furthertreatment.Oral infections Amoxicillin or ampicillin are as effectiveas phenoxymethylpenicillin (section 5.1.1.1) butthey are better absorbed; however, they may encourageemergence of resistant organisms.Like phenoxymethylpenicillin, amoxicillin and ampicillinare ineffective against bacteria that producebeta-lactamases. Co-amoxiclav is active against betalactamase-producingbacteria that are resistant toamoxicillin. Co-amoxiclav may be used <strong>for</strong> severedental infection with spreading cellulitis or dental infectionnot responding to first-line antibacterial treatment.AMOXICILLIN(Amoxycillin)Cautions see under Ampicillin; maintain adequatehydration with high doses (particularly during parenteraltherapy); interactions: Appendix 1 (penicillins)Contra-indications see under AmpicillinRenal impairment risk of crystalluria with high doses(particularly during parenteral therapy). Reduce dosein severe impairment; rashes more commonPregnancy not known to be harmfulBreast-feeding trace amounts in milk—not known tobe harmful but be alert <strong>for</strong> hypersensitivity in infantSide-effects see under AmpicillinIndication and doseSusceptible infections including urinary-tractinfections, sinusitis, uncomplicated community-acquiredpneumonia, oral infections (Table1, section 5.1), Lyme disease (see notesabove), salmonellosis. By mouthNeonate 7–28 days 30 mg/kg (max. 62.5 mg) 3times daily; dose doubled in severe infectionChild 1 month–1 year 62.5 mg 3 times daily; dosedoubled in severe infection, community-acquiredpneumonia, salmonellosis, or Lyme diseaseChild 1–5 years 125 mg 3 times daily; dosedoubled in severe infection, community-acquiredpneumonia, salmonellosis, or Lyme diseaseChild 5–18 years 250 mg 3 times daily; dosedoubled in severe infection, community-acquiredpneumonia, salmonellosis, or Lyme disease. By intravenous injection or infusionNeonate under 7 days 30 mg/kg every 12 hours;dose doubled in severe infection, communityacquiredpneumonia, or salmonellosisNeonate 7–28 days 30 mg/kg every 8 hours;dose doubled in severe infection, communityacquiredpneumonia, or salmonellosisChild 1 month–18 years 20–30 mg/kg (max.500 mg) every 8 hours; dose doubled in severeinfection (max. 4 g daily)Otitis media (but see Table 1, section 5.1). By mouthChild 1 month–18 years 40 mg/kg daily in 3divided doses (max. 1.5 g daily in 3 divided doses)Listerial meningitis (in combination withanother antibacterial, Table 1, section 5.1),group B streptococcal infection, enterococcalendocarditis (in combination with another antibiotic). By intravenous infusionNeonate under 7 days 50 mg/kg every 12 hours;dose may be doubled in meningitisNeonate 7–28 days 50 mg/kg every 8 hours;dose may be doubled in meningitisChild 1 month–18 years 50 mg/kg every 4–6hours (max. 2 g every 4 hours)Cystic fibrosis (treatment of asymptomatic H.influenzae carriage or mild exacerbations). By mouthChild 1 month–1 year 125 mg 3 times dailyChild 1–7 years 250 mg 3 times dailyChild 7–18 years 500 mg 3 times dailyHelicobacter pylori eradication section 1.3Note Amoxicillin doses in <strong>BNF</strong>C may differ from those inproduct literatureAdministration Displacement value may be significantwhen reconstituting injection, consult localguidelines. Dilute intravenous injection to a concentrationof 50 mg/mL (100 mg/mL <strong>for</strong> neonates). Maybe further diluted with Glucose 5% or Glucose 10% orSodium chloride 0.9% or 0.45% <strong>for</strong> intravenous infusion.Give intravenous infusion over 30 minutes whenusing doses over 30 mg/kgAmoxicillin (Non-proprietary) ACapsules, amoxicillin (as trihydrate) 250 mg, net price21 = £1.07; 500 mg, 21 = £1.31. Label: 9Brands include Amix c , Amoram c , Amoxident c , Galenamox c ,Rimoxallin cDental prescribing on NHS Amoxicillin Capsules may beprescribedOral suspension, amoxicillin (as trihydrate) <strong>for</strong>reconstitution with water, 125 mg/5 mL, net price5 Infections

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!